Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry) - 05/08/11
Doi : 10.1016/j.ahj.2010.06.016
Gen-Min Lin, MD 
Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei
Department of Internal Medicine, Hualien Armed Forces General Hospital, Hualien, Taiwan
Kai-Min Chu, MD, PhD
Division of Cardiology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Chih-Lu Han, MD, PhD
Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Le texte complet de cet article est disponible en PDF.
| The authors declare no conflict of interests and no financial support from any institutes. |
© 2010
Mosby, Inc. Tous droits réservés.
Vol 160 - N° 3
P. e21 - septembre 2010 Retour au numéro
Article précédent
- Vulnerable disease may induce neointimal coverage after silorimus-eluting stent implantation
- Masami Nishino, Shiro Hoshida, Masayuki Taniike, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Hitoshi Yamaguchi, Kenjiro Tanaka, Jun Tanouchi, Yoshio Yamada
- Response to letter regarding the article “Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation; Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)”
- Seung-Whan Lee, Seong-Wook Park
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?